SYDNEY, Australia, Nov. 8 /Xinhua-PRNewswire/ --
In the Lancet, on Tuesday, November, 6th new results of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) 2007 clinical trial have been published and presented on the same date at a press conference held during the AHA.
- First lipid modifying agent shown to reduce the need for treatment of
the leading causes of blindness and deteriorating vision in patients
with type 2 diabetes
- Reduces need for laser treatment in patients with and without known
diabetic retinopathy
- Significantly decreases progression of diabetic eye disease
If you are interested in knowing more about this breaking news
and in getting additional information on the management of microvascular
complications in type 2 diabetes, we are pleased to invite you to visit "the
Field Study Investigators Website," where you will have the opportunity to
login to the Webcast of the press conference.
Please click below: http://www.thefieldtrial.org
